We have collected information about Conor Drug Delivery Stent for you. Follow the links to find out details on Conor Drug Delivery Stent.
https://www.medscape.com/viewarticle/787937
Oct 15, 2019 · Conor's stent is called—somewhat ironically—the Co-Star and has several advantages over the currently approved models, in that it is highly deliverable and has a unique stent design ...
http://www.ptca.org/pr_conor/20060217.html
Conor Medsystems, Inc. develops innovative controlled vascular drug delivery technologies, and has initially focused on the development of drug- eluting stents to treat coronary artery disease. For further information on Conor Medsystems and controlled vascular delivery, visit www.conormed.com.
https://www.researchgate.net/publication/51104172_Stents_as_a_platform_for_drug_delivery
Stents as a platform for drug delivery, Expert Opinion on Drug Delivery, 8:6, 813-831, DOI: 10.1517/17425247.2011.572068. ... stent and doomed Conor ...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2929945/
Jul 15, 2010 · A drug-eluting stent (DES), namely, a stent combined with a drug, is designed to prevent ISR through inhibition of smooth muscle cell (SMC) proliferation. Generally, there are three components in DES: 1. stent platform; 2. drug delivery vehicle; 3. drug.Author: Jonathon Zhao, Lori Alquier
https://money.cnn.com/news/newsfeeds/articles/djf500/200611171151DOWJONESDJONLINE000792_FORTUNE5.htm
Nov 17, 2006 · J&J said the deal gives it access to a "controlled drug delivery technology," which Conor has used to develop the CoStar stent. CoStar is a drug-eluting stent currently available outside the U.S.
– Chairman of Progressive Angioplasty System (PAS), the developer of the stent delivery system for the original Palmaz-Schatz stent and other products. PAS was acquired by U.S. Surgical in 1997. – CEO and Chairman of Conor MedSystems, a developer of innovative drug eluting stent technology.
https://www.dicardiology.com/company/conor-medsystems-inc
May 7, 2007 — Citing issues related to potentially suboptimal therapeutic dosing of paclitaxel, Conor Medsystems, LL read more The CoStar drug-eluting stent by Conor MedSystems features tiny reservoirs that are filled with drugs and polymer.
https://www.dicardiology.com/content/cordis-gain-conor-stent-technology
Cordis to Gain Conor Stent Technology The companies announced their definitive agreement late last week. J&J’s acquisition of Conor will provide Cordis Corp. — also owned by J&J — with a unique controlled drug delivery technology that is currently employed on the CoStar Stent System, a paclitaxel-eluting cobalt chromium stent with a ...
http://www.ptca.org/pr_conor/20060420.html
MENLO PARK, Calif., April 20-- Conor Medsystems, Inc. (Nasdaq: CONR - News), a developer of innovative controlled vascular drug delivery technologies, today announced that the company has completed enrollment of 1,700 patients in its U.S. pivotal randomized clinical trial, COSTAR II (CObalt chromium STent with Antiproliferative for Restenosis).If the results of this clinical trial are ...
https://www.youtube.com/watch?v=UfChh_EBSVY
Jun 25, 2016 · Nanoscience and drug delivery -- small particles for big problems Taylor Mabe ... Conor Neill Recommended for you. 8:47. Robert S. Langer (MIT) Part 2: Drug Delivery Technology: ...Author: Haider Naqvi
Searching for Conor Drug Delivery Stent?
You can just click the links above. The data is collected for you.
